Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur Arch Otorhinolaryngol ; 269(6): 1713-9, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22350427

RESUMO

OBJECTIVES: Plasmablastic lymphoma (PBL) of the oral cavity is a rare form of non-Hodgkin lymphoma that is most frequently met in human immunodeficiency (HIV) positive patients. Only a few cases have been reported worldwide since 1997. This clinical entity may escape detection due to its unusual immunophenotype and rare occurrence. Our aim is to present two cases with this rare condition that were diagnosed and treated in our department. MATERIALS AND METHODS: We describe two cases of PBLs in HIV-infected patients, who presented with an expanding painless oral lesion and summarize the literature in order to elucidate the nature of this malignancy. RESULTS: The first patient received chemotherapy with additional radiotherapy that led to complete remission of the disease, while the second experienced a relapse 6 months after treatment with chemotherapy, that caused his death after refusal of further treatment. CONCLUSION: Because of the consistent epidemiological association of PBL with immunosuppression, any patient diagnosed with PBL should be tested for HIV. The clinical picture of PBL, including its affinity with HIV-infection, male sex, and its predilection for the oral cavity, may contribute to the differential diagnosis. Any oral mass occurring in an immunosuppressed patient should be referred for biopsy, since the early diagnosis of these tumors leads to better prognosis of the patients.


Assuntos
Infecções por HIV/complicações , Linfoma Relacionado a AIDS/complicações , Linfoma Imunoblástico de Células Grandes/complicações , Adulto , Antirretrovirais/uso terapêutico , Antineoplásicos/uso terapêutico , Diagnóstico Diferencial , Quimioterapia Combinada , Evolução Fatal , Infecções por HIV/tratamento farmacológico , Infecções por HIV/patologia , Humanos , Imunossupressores/uso terapêutico , Linfoma Relacionado a AIDS/patologia , Linfoma Relacionado a AIDS/terapia , Linfoma Imunoblástico de Células Grandes/patologia , Linfoma Imunoblástico de Células Grandes/terapia , Masculino , Pessoa de Meia-Idade , Radioterapia Adjuvante
2.
BMC Gastroenterol ; 10: 18, 2010 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-20152052

RESUMO

BACKGROUND: Individuals with impaired immunity are at higher risk of perianal diseases. Concerning complex anal fistulas impaired healing and complication rates are also higher. Definitive treatment of a fistula aims controlling the purulent discharge and prevents its recurrence. It depends mainly on the trajectory of the fistula and the underlying disease. We present a case of a HIV-positive patient with a complex extrasphincteric anal fistula who was treated successfully with fibrin glue application. We further, discuss tips and tricks when applying fibrin glue as plugging material in complex anal fistulas. CASE PRESENTATION: A sixty-one-year-old HIV-positive male referred to us for warts and extrasphincteric fistula. Because of the patients' immunological status, we opted against surgery and recommended fibrin glue plugging. The patient was discharged the same day. A follow-up examination was performed 5 days after the initial fibrin glue application showing that the fistula canal was obstructed. Three months and a year post-intervention the fistula tract remains closed. CONCLUSION: The best treatment for a disease gives at least the same result with the other treatments with minimised risk for the life of the patient and minimal application effort. Conservative closure of fistula with fibrin plugging is simple, safe and with less morbidity than surgery. Our patient was successfully treated without endangering his life despite his precarious medical state. Not everybody believes in the effectiveness of fibrin glue application, however we consider this solution in cases of complex fistulas at least as primary procedure in special populations such as the immunosupressed.


Assuntos
Soropositividade para HIV/complicações , Fístula Retal/tratamento farmacológico , Adesivo Tecidual de Fibrina/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Fístula Retal/etiologia , Adesivos Teciduais/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA